Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity

Addiction Biology

Volumn 20, Issue 4, 2015, Pages 756-772

  Araos, Pedro ^a   Pedraz, María ^a   Serrano, Antonia ^a   Lucena, Miguel ^a   Barrios, Vicente ^b   García Marchena, Nuria ^a   Campos Cloute, Rafael ^c   Ruiz, Juan J ^d   Romero, Pablo ^a   Suárez, Juan ^a   Baixeras, Elena ^a   De La Torre, Rafael ^e,f   Montesinos, Jorge ^g   Guerri, Consuelo ^g   Rodríguez Arias, Marta ^h   Miñarro, José ^h   Martínez Riera, Roser ^e,i,j   Torrens, Marta ^e,i,j   Chowen, Julie A ^b   Argente, Jesús ^b   Mason, Barbara J ^k   Pavõn, Francisco J ^a   De Fonseca, Fernando Rodríguez ^a   more..

^a Hospital R U de Málaga 82   (Spain)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^c Centro Comarcal de Drogodependencias   (Spain)

^d Centro de Tratamiento Ambulatorio   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^h UNIVERSITY OF VALENCIA   (Spain)

ⁱ Institut de Neuropsiquiatria i Addiccions (INAD) Parc de Salut Mar   (Spain)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k SCRIPPS RESEARCH INSTITUTE   (United States)

more..

Author keywords

Binge; chronic intoxication; cocaine; mice; PRISM; psychiatric co morbidity; substance use disorders

Indexed keywords

CHEMOKINE; CYTOKINE; FRACTALKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; CX3CL1 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDER; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BORDERLINE STATE; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DSM-IV-TR; FEMALE; GLIA CELL; HUMAN; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; MOUSE; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; SYMPTOM; TYPE B BEHAVIOR; ADOLESCENT; AGED; AMBULATORY CARE; ANIMAL; BLOOD; CASE CONTROL STUDY; COCAINE-RELATED DISORDERS; COMPLICATION; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PSYCHIATRIC DIAGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANIMALS; CASE-CONTROL STUDIES; CHEMOKINE CX3CL1; CHEMOKINE CXCL12; CHEMOKINES; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; CYTOKINES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INTERLEUKIN-1BETA; MALE; MENTAL DISORDERS; MICE; MIDDLE AGED; YOUNG ADULT;

EID: 84930801833     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12156     Document Type: Article

References (56)

1. Bachstetter AD, Morganti JM, Jernberg J, Schlunk A, Mitchell SH, Brewster KW, Hudson CE, Cole MJ, Harrison JK, Bickford PC, Gemma C, (2011) Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging 32: 2030-2044.
2. Baldwin GC, Roth MD, Tashkin DP, (1998) Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 83: 133-138.
3. Boulanger LM, (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64: 93-109.
4. Brietzke E, Mansur RB, Soczynska JK, Kapczinski F, Bressan RA, McIntyre RS, (2012) Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J Affect Disord 140: 82-91.
5. Cearley CN, Blindheim K, Sorg BA, Krueger JM, Churchill L, (2011) Acute cocaine increases interleukin-1 beta mRNA and immunoreactive cells in the cortex and nucleus accumbens. Neurochem Res 36: 686-692.
6. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni MG, Fredholm BB, Eusebi F, Limatola C, (2011) CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci 31: 16327-16335.
7. Coller JK, Hutchinson MR, (2012) Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol Ther 134: 219-245.
8. Crews FT, Zou J, Qin L, (2011) Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun 25 (Suppl. 1): S4-S12.
9. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW, (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56.
10. Degenhardt L, Singleton J, Calabria B, McLaren J, Kerr T, Mehta S, Kirk G, Hall WD, (2011) Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 113: 88-95.
11. Di Francesco P, Marini S, Pica F, Favalli C, Tubaro E, Garaci E, (1992) In vivo cocaine administration influences lymphokine production and humoral immune response. Immunol Res 11: 74-79.
12. Diercks DB, Fonarow GC, Kirk JD, Jois-Bilowich P, Hollander JE, Weber JE, Wynne J, Mills RM, Yancy C, Peacock WF, (2008) Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). Am J Cardiol 102: 1216-1219.
13. Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, Shapshak P, Stins M, Kim KS, Witte M, Chang SL, (1998) Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv Exp Med Biol 437: 199-205.
14. Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH, (2013) Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses 29: 1110-1116.
15. Guyon A, Skrzydelski D, De Giry I, Rovere C, Conductier G, Trocello JM, Dauge V, Kitabgi P, Rostene W, Nahon JL, Melik Parsadaniantz S, (2009) Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 162: 1072-1080.
16. Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd, (2012) Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther 134: 260-277.
17. Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR, (2004) Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci 1025: 47-56.
18. Halpern JH, Sholar MB, Glowacki J, Mello NK, Mendelson JH, Siegel AJ, (2003) Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J Clin Endocrinol Metab 88: 1188-1193.
19. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R, (2006) Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 163: 689-696.
20. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J, (1996) Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 153: 1195-1201.
21. Hasin DS, Fenton MC, Beseler C, Park JY, Wall MM, (2012) Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend 122: 28-37.
22. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF, (2013) DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 170: 834-851.
23. Heinisch S, Kirby LG, (2009) Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience 164: 1210-1223.
24. Heinisch S, Kirby LG, (2010) SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuropharmacology 58: 501-514.
25. Herrero MJ, Domingo-Salvany A, Torrens M, Brugal MT, ITINERE Investigators (2008) Psychiatric comorbidity in young cocaine users: induced versus independent disorders. Addiction 103: 284-293.
26. Irwin MR, Olmos L, Wang M, Valladares EM, Motivala SJ, Fong T, Newton T, Butch A, Olmstead R, Cole SW, (2007) Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. J Pharmacol Exp Ther 320: 507-515.
27. Jankowski MM, Ignatowska-Jankowska B, Glac W, Swiergiel AH, (2010) Cocaine administration increases CD4/CD8 lymphocyte ratio in peripheral blood despite lymphopenia and elevated corticosterone. Int Immunopharmacol 10: 1229-1234.
28. Kelly TM, Daley DC, Douaihy AB, (2012) Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 37: 11-24.
29. Koprich JB, Reske-Nielsen C, Mithal P, Isacson O, (2008) Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflammation 5: 8.
30. Kubera M, Filip M, Budziszewska B, Basta-Kaim A, Wydra K, Leskiewicz M, Regulska M, Jaworska-Feil L, Przegalinski E, Machowska A, Lason W, (2008) Immunosuppression induced by a conditioned stimulus associated with cocaine self-administration. J Pharmacol Sci 107: 361-369.
31. Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Hoi Yu AC, (2011) Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 8: 67-80.
32. Mandyam CD, Koob GF, (2012) The addicted brain craves new neurons: putative role for adult-born progenitors in promoting recovery. Trends Neurosci 35: 250-260.
33. Miller AH, (2009) Norman cousins lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23: 149-158.
34. Miller AH, Maletic V, Raison CL, (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732-741.
35. Montgomery SL, Bowers WJ, (2012) Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol 7: 42-59.
36. Morgello S, Holzer CE 3rd, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ, (2006) Interrater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res 15: 131-138.
37. O'Brien CP, (2008) Review. Evidence-based treatments of addiction. Philos Trans R Soc Lond B Biol Sci 363: 3277-3286.
38. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT, (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333: 1456-1458.
39. Pavon FJ, Araos P, Pastor A, Calado M, Pedraz M, Campos-Cloute R, Ruiz JJ, Serrano A, Blanco E, Rivera P, Suarez J, Romero-Cuevas M, Pujadas M, Vergara-Moragues E, Gornemann I, Torrens M, de la Torre R, Rodriguez de Fonseca F, (2013) Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity. Addict Biol 18: 955-969.
40. Robertson K, (2010) The EMCDDA annual report 2010: the state of the drugs problem in Europe. Euro Surveill 15: 19714.
41. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA, Sartorius N, Towle LH, (1988) The Composite International Diagnostic Interview-an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiat 45: 1069-1077.
42. Rodriguez-Arias M, Castillo A, Daza-Losada M, Aguilar MA, Minarro J, (2009) Effects of extended cocaine conditioning in the reinstatement of place preference. Physiol Behav 96: 620-630.
43. Rofael HZ, Turkall RM, Abdel-Rahman MS, (2003) Immunomodulation by cocaine and ketamine in postnatal rats. Toxicology 188: 101-114.
44. Roncero C, Ros-Cucurull E, Daigre C, Casas M, (2012) Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas Esp Psiquiatr 40: 187-197.
45. Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D, (2012) Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. J Neurosci 32: 13896-13905.
46. Salim S, Chugh G, Asghar M, (2012) Inflammation in anxiety. Adv Protein Chem Struct Biol 88: 1-25.
47. Stevens L, Betanzos-Espinosa P, Crunelle CL, Vergara-Moragues E, Roeyers H, Lozano O, Dom G, Gonzalez-Saiz F, Vanderplasschen W, Verdejo-Garcia A, Perez-Garcia M, (2013) Disadvantageous decision-making as a predictor of drop-out among cocaine-dependent individuals in long-term residential treatment. Front Psychiatry 4: 149.
48. Stuart MJ, Baune BT, (2014) Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci Biobehav Rev 42C: 93-115.
49. Stuart MJ, Corrigan F, Baune BT, (2014) Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus. J Neuroinflammation 11: 31.
50. Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, Brandon NJ, (2012) Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2: e199.
51. Thomas MJ, Kalivas PW, Shaham Y, (2008) Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154: 327-342.
52. Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R, (2004) Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry 161: 1231-1237.
53. Trecki J, Unterwald EM, (2009) Modulation of cocaine-induced activity by intracerebral administration of CXCL12. Neuroscience 161: 13-22.
54. Trocello JM, Rostene W, Melik-Parsadaniantz S, Godefroy D, Roze E, Kitabgi P, Kuziel WA, Chalon S, Caboche J, Apartis E, (2011) Implication of CCR2 chemokine receptor in cocaine-induced sensitization. J Mol Neurosci 44: 147-151.
55. Wang Y, Huang DS, Watson RR, (1994) In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci 54: 401-411.
56. Yamada K, Nabeshima T, (2004) Pro- and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini review. Ann N Y Acad Sci 1025: 198-204.